Skip to content

Ranger™ H74939419601590Recalls & reported problems

Boston Scientific Corporation · Paclitaxel-Coated PTA Balloon Catheter · Class 3

All models of Ranger (50)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08714729976196), received between Sep 1, 2021 and May 7, 2025 — classified as 5 malfunctions.

The most frequently reported specific device problem is “Material Rupture” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Rupture3
  • Device Contamination with Chemical or Other Material1
  • Entrapment of Device1

Patient problems

  • No Clinical Signs, Symptoms or Conditions5

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 7, 2025Material Rupture; Material Rupture

    IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MODERATELY CALCIFIED SUPERFICIAL FEMORAL ARTERY. A 6.0 X 150MM, 90CM RANGER? BALLOON CATHETER WAS ADVANCED FOR DILATION. DURING THE PROCEDURE, THE BALLOON RUPTURED UPON FIRST INFLATION AT 6 ATMOSPHERES. THE DEVICE WAS REMOVED WITHOUT ANY PROBLEM, AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21979099 ↗
  • MalfunctionApr 23, 2025Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    IT WAS REPORTED THAT DEVICE CONTAMINATION OCCURRED. THE 75% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS SUPERFICIAL FEMORAL ARTERY. A 6.0 X 150MM, 90CM RANGER DRUG-COATED BALLOON WAS SELECTED FOR USE. HOWEVER, TWO THREAD-LIKE FOREIGN OBJECTS WERE NOTED ON THE DEVICE. THEY WERE PULLED BY FINGER, PEELED OFF FROM THE RANGER BALLOON, AND THE PROCEDURE WAS COMPLETED USING THIS DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21893680 ↗
  • MalfunctionMar 6, 2024Entrapment of Device; Entrapment of Device

    IT WAS REPORTED THAT CATHETER ENTRAPMENT OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED LEFT SUPERFICIAL FEMORAL ARTERY. A 6.0 X 150MM, 90CM RANGER PACLITAXEL-COATED PTA BALLOON CATHETER WAS ADVANCED FOR DILATION. DURING THE PROCEDURE, IT WAS NOTED THAT THE BALLOON BECAME STUCK WITH A 014 NON-BOSTON SCIENTIFIC GUIDEWIRE. BOTH DEVICES WERE REMOVED AS A SINGLE UNIT. THE PROCEDURE WAS COMPLETED USING THIS DEVICE. NO COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18848441 ↗
  • MalfunctionOct 19, 2021Material Rupture; Material Rupture

    IT WAS REPORTED THAT THE BALLOON RUPTURED. A 6.0 X 150MM, 90CM RANGER DRUG-COATED BALLOON WAS SELECTED FOR USE IN A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PROCEDURE IN THE LEFT SUPERFICIAL FEMORAL ARTERY (SFA). THE TARGET LESION WAS 99% STENOSED WITH MODERATE CALCIFICATION AND TORTUOSITY. THE BALLOON WAS INFLATED AT 8 ATM FOR 20 SECONDS DURING THE FIRST INFLATION AT WHICH POINT IT RUPTURED. THE BALLOON WAS REMOVED. A NEW DEVICE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12662208 ↗
  • MalfunctionSep 1, 2021Material Rupture; Material Rupture

    IT WAS REPORTED THAT THE BALLOON RUPTURED. A 6.0 X 150MM, 90CM RANGER PACLITAXEL-COATED PTA BALLOON CATHETER WAS SELECTED FOR A PATIENT PROCEDURE IN THE RIGHT SUPERFICIAL FEMORAL ARTERY. THE PATIENT HAD PERIPHERAL ARTERY DISEASE. THE LESION WAS SEVERELY TORTUOUS, 99% STENOSED, AND MODERATELY CALCIFIED. DURING THE PROCEDURE, INSIDE OF THE PATIENT, THE BALLOON RUPTURED AT 10ATM DURING THE FIRST INFLATION. THE SHAPE OF THE RUPTURE WAS A PINHOLE. THE DEVICE WAS REMOVED WITHOUT ANY PROBLEMS. THE PATIENT WAS IN GOOD CONDITION AFTER THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12408917 ↗

Other Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices

All Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page